{
    "code": "52027263",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027263",
    "time": "2019-05-03 03:08:34",
    "許可證字號": "衛部藥輸字第027263號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/11\/17",
    "發證日期": "106\/11\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202726300",
    "中文品名": "普澤力膜衣錠",
    "英文品名": "Prezcobix Flim-Coated Tablets",
    "適應症": "「適用於與其他抗反轉錄病毒藥物併用，以治療未曾接受治療及曾經接受治療且\r\n未發生darunavir 抗藥性相關取代 (V11I、V32I、L33F、I47V、I50V、I54L、I54M、\r\nT74P、L76V、I84V、L89V) 的人類免疫缺乏病毒(HIV-1)感染之成人患者」。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠塑膠瓶裝(HDPE)",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "DARUNAVIRETHANOLATE,cobicistat"
    ],
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F370062000  JANSSEN ORTHO LLC",
        "製造廠廠址": "STATE ROAD 933 KM 0.1 MAMEY WARD, GURABO, PUERTO RICO, 00778",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F250332000  JANSSEN-CILAG S.P.A.",
            "製造廠廠址": "VIA C. JANSSEN 04100 BORGO S. MICHELE-LATINA, ITALY",
            "製造廠公司地址": "VIA M. BUONARROTI 23 20093 COLOGNO MONZESE ITALY",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818003610",
            "成分名稱": "DARUNAVIR ETHANOLATE",
            "含量描述": "(eq to Darunavir......800MG)",
            "含量": "867.2800000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200082600",
            "成分名稱": "cobicistat",
            "含量描述": "(non-adsorbet)",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Prezcobix Label_v01_New_684127-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027263&Seq=004&Type=9"
        },
        {
            "title": "Prezcobix Carton_v01_679751-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027263&Seq=003&Type=9"
        },
        {
            "title": "[打樣版] Prezcobix_USPI Jun2018+EUPI Apr2017(GS-US-216-130 study)_v1801_0710-107-10-30.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027263&Seq=002&Type=9"
        },
        {
            "title": "[打樣版] Prezcobix_USPI Jun2017+EUPI Apr2017(GS-US-216-130 study)_v1701_1222-106-12-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027263&Seq=001&Type=9"
        },
        {
            "title": "1220-Prezcobix label-2017-106-12-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027263&Seq=002&Type=8"
        },
        {
            "title": "1220-Prezcobix carton-2017-106-12-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027263&Seq=001&Type=8"
        }
    ]
}